Viking Therapeutics, Inc. (VKTX)
24.40
-1.43
(-5.54%)
USD |
NASDAQ |
Oct 23, 16:00
24.43
+0.03
(+0.12%)
After-Hours: 20:00
Viking Therapeutics Price : 24.40 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 25.54 | 25.74 | 24.36 | 24.40 | 4.675M |
| Oct 22, 2026 | 26.36 | 26.79 | 25.66 | 25.83 | 3.531M |
| Oct 21, 2026 | 26.83 | 27.29 | 26.31 | 26.38 | 3.295M |
| Oct 20, 2026 | 25.10 | 26.92 | 25.00 | 26.71 | 4.657M |
| Oct 19, 2026 | 25.40 | 25.81 | 25.02 | 25.05 | 3.741M |
| Oct 16, 2026 | 27.17 | 27.34 | 24.94 | 25.17 | 7.582M |
| Oct 15, 2026 | 26.10 | 27.51 | 25.86 | 27.37 | 5.225M |
| Oct 14, 2026 | 26.50 | 26.88 | 25.28 | 25.47 | 6.581M |
| Oct 13, 2026 | 28.20 | 28.20 | 26.60 | 26.65 | 5.739M |
| Oct 12, 2026 | 28.23 | 28.84 | 27.91 | 28.34 | 2.862M |
| Oct 09, 2026 | 27.85 | 28.86 | 27.58 | 28.51 | 4.046M |
| Oct 08, 2026 | 28.37 | 28.49 | 27.05 | 27.73 | 8.733M |
| Oct 07, 2026 | 28.39 | 29.06 | 28.12 | 28.54 | 5.410M |
| Oct 06, 2026 | 29.49 | 29.72 | 28.17 | 28.38 | 7.110M |
| Oct 05, 2026 | 30.14 | 30.18 | 28.71 | 29.28 | 6.277M |
| Oct 02, 2026 | 30.85 | 31.09 | 29.90 | 29.94 | 6.367M |
| Oct 01, 2026 | 31.92 | 32.48 | 30.43 | 30.51 | 6.832M |
| Sep 30, 2026 | 31.86 | 33.29 | 31.20 | 32.60 | 7.000M |
| Sep 29, 2026 | 33.11 | 33.65 | 31.42 | 31.81 | 8.026M |
| Sep 28, 2026 | 35.00 | 35.19 | 32.91 | 33.03 | 8.575M |
| Sep 25, 2026 | 37.80 | 39.05 | 35.10 | 35.56 | 13.58M |
| Sep 24, 2026 | 36.02 | 37.22 | 35.11 | 36.75 | 28.71M |
| Sep 23, 2026 | 41.76 | 43.10 | 37.71 | 41.65 | 15.73M |
| Sep 22, 2026 | 37.00 | 41.73 | 36.34 | 40.85 | 41.23M |
| Sep 21, 2026 | 29.57 | 30.70 | 28.41 | 30.11 | 5.087M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1273.46 |
| Regeneron Pharmaceuticals, Inc. | 805.02 |
| Ironwood Pharmaceuticals, Inc. | 3.46 |
| Compass Therapeutics, Inc. | 0.761 |
| Structure Therapeutics, Inc. | 21.19 |
Price Related Metrics
| PEG Ratio | -0.0257 |
| Price to Book Value | 6.971 |
| Earnings Yield | -19.11% |
| Market Cap | 2.846B |
| PEGY Ratio | -0.0257 |